Company Search:
Advanced Search
Sponsored Links
Galectin Therapeutics Incorporated Company Snapshot

Sales Analysis.
  Stock Performance Chart for Galectin Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 5.64
(Figures in U.S. Dollars)
1 Week -3.9%   13 Weeks 118.6%  
4 Weeks 112.0%   52 Weeks 458.4%  
Galectin Therapeutics Incorporated Key Data:
  Ticker: GALT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2000 Sales
(Year Ending Jan 2001).
Employees: 7
  Currency: U.S. Dollars Market Cap: 201,002,257
  Fiscal Yr Ends: December Shares Outstanding: 35,638,698
  Share Type: Common Closely Held Shares: 7,474,601
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.